Jones Hill Capital »

Tonix Pharmaceuticals Hldg shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg (TNXP) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Tonix Pharmaceuticals Hldg

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2M 452k 13.75

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Vertex Pharmaceuticals Incorporated (VRTX)
Vaxcyte (PCVX)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)
Terns Pharmaceuticals (TERN)
Bicara Therapeutics (BCAX)
Biosante Pharmaceuticals (ANIP)
Ultragenyx Pharmaceutical (RARE)
Enliven Therapeutics (ELVN)
Amylyx Pharmaceuticals (AMLX)
Argenx Se Sponsored Adr (ARGX)
Fulcrum Therapeutics (FULC)
Vir Biotechnology (VIR)
Nuvation Bio Com Cl A (NUVB)

View all positions for Jones Hill Capital

Top funds holding Tonix Pharmaceuticals Hldg

BlackRock
Vanguard Group
Vanguard Capital Management
Citadel Advisors
Jones Hill Capital
Geode Capital Management
Balyasny Asset Management
UBS Group
Millennium Management
State Street Corporation
Northern Trust
AQR Capital Management
Point72 Asset Management
Jane Street
Nuveen

View all funds holding Tonix Pharmaceuticals Hldg